- Current Perspectives in C. difficile Infection
- Individualizing Treatment Approaches in Primary CDI Episodes
- Strategies for Optimization in Complex Recurrent CDI Settings
- Audience Question and Answer Session
Date / Time
Carolyn D. Alonso, MD
Assistant Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Harvard Medical School
Transplant & Immunocompromised Host ID Program
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
Paul Feuerstadt, MD, FACG, AGAF
Assistant Clinical Professor of Medicine
Department of Gastroenterology
Yale University School of Medicine
Kevin Garey, PharmD, MS
Professor and Chair
Department of Pharmacy Practice and Translational Research
University of Houston College of Pharmacy
The goal of this activity is to improve learners’ knowledge, competence, and performance in applying the latest practice guidelines and data to provide patient-centered care in the management of Clostridioides difficile infections.
This program is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients with Clostridioides difficile infections.
Upon completion of this activity, participants should be able to:
- Accurately compare new clinical practice guidelines on CDI management to apply best practices to individual clinical scenarios
- In partnership with patients, develop tailored and comprehensive treatment plans for CDI
- Integrate co-interventions into CDI regimens to optimize long-term outcomes
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
Continuing Pharmacy Education
CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-23-014-L01-P
Type of Activity: Application
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.